Home › NDC Lookup › RxCUI directory › RxCUI 484322

Insulin detemir 100 UNT/ML Injectable Solution — RxCUI 484322

RxNorm drug concept · Semantic clinical drug
RxCUI 484322 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI484322
Official nameInsulin detemir 100 UNT/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asinsulin analog, detemir 100 UNT/ML Injectable Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)7,960 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Detemir (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a long-acting insulin that helps control blood sugar in adults and children with diabetes mellitus. It isn't recommended for diabetic ketoacidosis, which needs emergency care.
  • You inject it under the skin of your thigh, upper arm, or belly, once or twice a day. Once-daily doses go with the evening meal or at bedtime. Rotate spots within the same area, an...
  • Low blood sugar is the most common one. You may also get colds, headache, sore throat, or skin reactions at the injection site. Keep checking your glucose as directed.
  • Mild lows are usually treated with glucose by mouth. Severe lows with seizure or passing out are emergencies and may need glucagon or IV glucose. Don't take insulin during a low, a...
📖 Read our full Insulin Detemir (rDNA Origin) Injection guide →

🕸️ Concept Web — How Insulin detemir 100 UNT/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Insulin detemir 100 UNT/ML Injectable Solution RxCUI 484322

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Insulin detemir 139825
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Levemir 400560
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Insulin detemir Injectable Solution 484321
    • Insulin detemir Injectable Product 1160696
    • Insulin detemir Injectable Solution [Levemir] 616237
    • Levemir Injectable Product 1167934
    • Injectable Solution 316949
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Insulin detemir 100 UNT/ML SCDC · 484320
  • Insulin detemir Injectable Solution SCDF · 484321
  • Insulin detemir Injectable Product SCDG · 1160696

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 484322 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00169-3687-12 1 VIAL, GLASS in 1 CARTON (0169-3687-12) / 10 mL in 1 VIAL,... Levemir Novo Nordisk 2006-03-27
50090-1276-00 1 VIAL, GLASS in 1 CARTON (50090-1276-0) / 10 mL in 1 VIAL,... Levemir A-S Medication Solutions 2014-11-28
Observed labelers: A-S Medication Solutions (1) · Novo Nordisk (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$10.3614
Range $10.3614–$10.3614 · middle 50% $10.3614–$10.3614 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.